Search
Actinium Pharmaceuticals Inc
ATNMAdd to Watchlist
0.981USD
+0.005+0.51%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
30.60MMarket Cap
LossP/E TTM
Actinium Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Actinium Pharmaceuticals Inc is 6.41, ranking 333 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.30, which is -40.09% below the recent high of -0.78 and -699.41% above the recent low of -10.43.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.